IVI RMA GLOBAL
Marta Garcia Sanchez is a highly experienced gynecologist and reproductive specialist, currently serving as a gynecologist at IVI RMA GLOBAL and a principal investigator at Ferring Pharmaceuticals since April 2023. Additionally, Marta holds a position as a board member for the Reproductive Section of the Sociedad Andaluza de Ginecología y Obstetricia. Marta has extensive clinical research experience, having worked as a principal investigator at Quirónsalud since 2010, focusing on clinical trials in gynecology, obstetrics, and assisted reproduction. With a background in assisted reproduction techniques and prenatal diagnosis, Marta has also held leadership roles in coordinating medical teams and units. Educational qualifications include a degree in Medicine from Universidad de Málaga and specialized training in gynecological center management. Training in music complements Marta's diverse skill set.
This person is not in any offices
IVI RMA GLOBAL
3 followers
IVIRMA Global is the world’s premier fertility group that leads the industry in research, success rates and patient care. From clinical excellence, to research and innovation, to teaching the next generation of reproductive endocrinologists, to advancing cutting edge protocols, standards and practices in the field. The acronyms IVI and RMA represent the two best assisted reproduction groups in Europe and the U.S., respectively. Together, they have since the beginning of the nineties been setting the standard in the field of reproduction, until in February 2017 they decided to merge to form the largest Reproductive Medicine group in the world. IVI was founded in 1990 by Professors José Remohí and Antonio Pellicer, and became a leader in fertility treatment in Europe and Latin America. RMA was founded in 1999 by Drs. Paul Bergh, Richard Scott and Michael Drews, quickly becoming a leader in reproductive medicine in the United States. IVI and RMA both place great importance on research, high-quality scientific results, and a common culture with a single objective: to achieve the best results for patients. • 75 Clinical Offices & 28 Labs in 9 Countries • +465 Physicians & Embryologists • +2300 Employees • +100 babies born daily thanks to IVIRMA Research & Development… • +2500 Publications • 69 Researchers • 7 Researcher centers